China Rare Earth Resources And Technology (00769): Guo Jinying resigns as an executive director and acting chairman of the board
China Rare Earth (00769) announced that starting from June 12, 2026: (1) Ms. Guo Jinying has tendered her resignation as an executive director and acting chairman of the board, as she has decided to devote more time to other business commitments.
China Rare Earth Resources And Technology (00769) announced that effective from June 12, 2026:
(1) Ms. Guo Jinying has resigned as an executive director and acting chairman of the board, as she has decided to devote more time to other business responsibilities;
(2) Mr. Kang Ding has resigned as an executive director, as he has decided to devote more time to other business responsibilities;
(3) Professor Ye Shiwei has resigned as an independent non-executive director, chairman of the company's audit committee, and a member of the company's remuneration committee and nomination committee respectively, as he has decided to devote more time to other business responsibilities; and
(4) Ms. Xu Meifeng has resigned as the company secretary, authorized representative under Rule 3.05 of the Listing Rules, and authorized representative in Hong Kong for the purpose of receiving legal process documents or notices pursuant to Rule 19.05(2) of the Listing Rules and section 16 of the Hong Kong Companies Ordinance (Chapter 622).
Related Articles

Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!

RECOMMEND





